K Number
K052166
Device Name
MODIFICATION TO: RX ACCUNET EMBOLIC PROTECTION SYSTEM
Date Cleared
2005-08-18

(9 days)

Product Code
Regulation Number
870.1250
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The RX ACCUNET™ Embolic Protection System is indicated for use as a guide wire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.25 mm and 7.0 mm.
Device Description
The RX ACCUNET™ Embolic Protection System is a filtration type embolic protection device, filtering distal to the interventional site. The System consists of the RX ACCUNET™ Delivery System, the RX ACCUNET Recovery Catheter, Shapeable Tip Design and the RX ACCUNET™ 2 Recovery Catheter, Low-Profile, Flexible Tip Design all packaged together in one chipboard carton. The RX ACCUNET™ Embolic Protection System is delivered via a Delivery Sheath with a flexible tip coil that facilitates movement of the Sheath through tortuous anatomy. Once across the lesion, the Filter Basket is expanded in the arterial lumen by peeling the Delivery Sheath from the guide wire using the torque device and peel away adapter. At the conclusion of the interventional procedure, the Filter Basket is collapsed inside one of the provided Recovery Catheters. Recovery Catheter selection will be based on physician preference and/or patient anatomy. Once collapsed, the entire system is removed as a single unit. The Recovery Catheters have radiopaque tips to facilitate movement though tortuous anatomy.
More Information

No
The device description focuses on mechanical components and filtration, with no mention of AI/ML terms or functionalities.

Yes
The device is used to contain and remove embolic material, which is a therapeutic intervention during angioplasty and stenting procedures.

No

This device is designed to contain and remove embolic material during angioplasty and stenting procedures, which is a therapeutic function, not a diagnostic one.

No

The device description clearly outlines physical components like a delivery system, recovery catheters, and a filter basket, indicating it is a hardware-based medical device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to "contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries." This describes a surgical/interventional procedure performed directly on the patient's body.
  • Device Description: The device description details a physical system of catheters, guide wires, and a filter basket designed for mechanical intervention within the carotid artery.
  • Lack of Diagnostic Function: There is no mention of the device being used to analyze samples (blood, tissue, etc.) or provide diagnostic information about a patient's condition. IVDs are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.

The RX ACCUNET™ Embolic Protection System is a medical device used during a medical procedure, not for in vitro diagnostic testing.

N/A

Intended Use / Indications for Use

The RX ACCUNET™ Embolic Protection System is indicated for use as a guide wire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.25 mm and 7.0 mm.

Product codes

NTE

Device Description

The RX ACCUNET™ Embolic Protection System is a filtration type embolic protection device, filtering distal to the interventional site. The System consists of the RX ACCUNET™ Delivery System, the RX ACCUNET Recovery Catheter, Shapeable Tip Design and the RX ACCUNET™ 2 Recovery Catheter, Low-Profile, Flexible Tip Design all packaged together in one chipboard carton. The RX ACCUNET™ Embolic Protection System is delivered via a Delivery Sheath with a flexible tip coil that facilitates movement of the Sheath through tortuous anatomy. Once across the lesion, the Filter Basket is expanded in the arterial lumen by peeling the Delivery Sheath from the guide wire using the torque device and peel away adapter. At the conclusion of the interventional procedure, the Filter Basket is collapsed inside one of the provided Recovery Catheters. Recovery Catheter selection will be based on physician preference and/or patient anatomy. Once collapsed, the entire system is removed as a single unit. The Recovery Catheters have radiopaque tips to facilitate movement though tortuous anatomy.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

carotid arteries

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription Use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The results of the packaging integrity studies have demonstrated the safety and effectiveness of the proposed RX ACCUNET™ Embolic Protection System "3 in 1 packaging configuration."

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K042218, K042908

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1250 Percutaneous catheter.

(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).

0

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image is a black and white logo for the Department of Health and Human Services, USA. The logo features a stylized image of an eagle with three heads, representing the three branches of government. The eagle is surrounded by a circular border with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" written around it.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 2 8 2005

Guidant Endovascular Solutions c/o Ms. Julia Anastas Advisor, Regulatory Affairs 3200 Lakeside Drive Santa Clara, CA 95054

Re: K052166

RX ACCUNET™ Embolic Protection System Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: NTE Dated: August 8, 2005 Received: August 9, 2005

Dear Ms. Anastas:

This letter corrects our substantially equivalent letter of August 18, 2005.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Page 2 - Ms. Julia Anastas

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address

http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Dmnel R. Vichner

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known): K052166

Device Name:

RX ACCUNET™ Embolic Protection System

Indications For Use:

The RX ACCUNET™ Embolic Protection System is indicated for use as a guide wire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.25 mm and 7.0 mm.

Prescription Use × (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Auley B. Bvan
(Division Sign-Off)

Division of Cigit Off
Division of Cardiovascular Devices

Page 1 of _1

510(k) Number_KO5266

3

K052166 p. 1 of 2

RX ACCUNET™ Embolic Protection System "3 in 1 Packaging Configuration" Special 510(k)

GUIDANT

AUG 1 8 2005

510(k) SUMMARY

The 510(k) Summary is submitted in accordance with 21 CFR Part 807, Section 807.92

Submitter's Name:Guidant Corporation
Submitter's Address:3200 Lakeside Drive
Santa Clara, CA 95052
Telephone:
Fax:408-845-2201
408-845-2304
Contact Person:Julia Anastas
Date Prepared:August 8, 2005
Device Trade Name:RX ACCUNET™ Embolic Protection System
Device Common Name:Embolic Protection System
Device Classification Name:Embolic Protection System
Device Classification:Class II

Summary of Substantial Equivalence:

The proposed RX ACCUNET™ Embolic Protection System "3 in 1 packaging configuration" is substantially equivalent to the currently marketed RX ACCUNET™ Embolic Protection System and RX ACCUNET™ 2 Recovery Catheter.

Device Description:

The RX ACCUNET™ Embolic Protection System is a filtration type embolic protection device, filtering distal to the interventional site. The System consists of the RX ACCUNET™ Delivery System, the RX ACCUNET Recovery Catheter, Shapeable Tip Design and the RX ACCUNET™ 2 Recovery Catheter, Low-Profile, Flexible Tip Design all packaged together in one chipboard carton. The RX ACCUNET™ Embolic Protection System is delivered via a Delivery Sheath with a flexible tip coil that facilitates movement of the Sheath through tortuous anatomy. Once across the lesion, the Filter Basket is expanded in the arterial lumen by peeling the Delivery Sheath from the guide wire using the torque device and peel away adapter. At the conclusion of the interventional procedure, the Filter Basket is collapsed inside one of the provided Recovery Catheters. Recovery Catheter selection will be based on physician preference and/or patient anatomy. Once collapsed, the entire system is removed as a single unit. The Recovery Catheters have radiopaque tips to facilitate movement though tortuous anatomy.

Confidential

4

Intended Use:

The RX ACCUNET™ Embolic Protection System is indicated for use as a guide wire and The KX AOOONE T - Embolio Protoction and remove embolic material (thrombus / debris) while embolic protection oyoton to contain or carotid arteries. The diameter of the performing anglopidsty and cloning promote should be between 3.25 mm and 7.0 mm.

Technological Characteristics:

No changes were made to any of the individual components of the RX ACCUNET™ Embolic Protection System.

The RX ACCUNET™ Embolic Protection System is substantially equivalent to the RX The RX ACCONET - Embolic Protection Systems (K042218) and the RX ACCUNET™ 2 Recovery Catheter (K042908) with regard to device design, principles of operation, materials, and Oather (189200) with rogard to asign attributes are the same or similar for both the subiect device and the predicate device:

  • Rapid exchange systems .
  • Filter based technology .
  • Polvurethane filter membrane .
  • Nitinol filter/basket component .
  • Compatibility with .014" guidewires ●
  • Compatibility with 6F guide catheters .
  • Available in 190 and/or 300 cm lengths .
  • Accommodates same vessel sizes .
  • Radiopaque guidewire tips and/or delivery sheath tips .
  • Radiopaque markers on filter ●
  • Delivery System /Recovery Catheter compatability

Comparisons of the subject and predicate devices show that technological characteristics Such as materials, biocompatibility, performance properties, sterilization and packaging are substantially equivalent to the currently marketed predicate devices.

Performance Data:

The results of the packaging integrity studies have demonstrated the safety and effectiveness of the proposed RX ACCUNET™ Embolic Protection System "3 in 1 packaging configuration."